Research and Development (R&D)
Delytact: The world’s first oncolytic virotherapy for brain cancer
The world's first oncolytic virus therapy for brain cancer was approved earlier this month - but it was not, as…
EU countries make inroads in COVID-19 vaccination race even as supply concerns linger
While daily news across Europe are filled with doom-and-gloom reports of delays in the roll-out of COVID-1 vaccines, the latest…
COVID19 Research and Development Tracker: Vaccine rollouts, dosing controversies and new strains
In the latest edition of our Weekly COVID19 R&D Tracker, which has tracked progress and expected timelines of vaccines and…
Pfizer and BioNTech’s COVID-19 vaccine
Pfizer (US) and partner BioNTech (Germany) have announced that a two-dose schedule of their mRNA-based COVID-19 vaccine candidate, BNT162b2, has…
Mixed news on COVID19 vaccines: COVID-19 R&D tracker
In the latest edition of our Weekly COVID19 R&D Tracker, which has tracked progress and expected timelines of vaccines and…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
COVID-19 treatments: No magic bullet
As communities, states, and countries begin to reopen, the question top-of-mind for many is when will a vaccine, or other…
The race intensifies for a COVID-19 vaccine as hope builds for emergency approval by September
As the COVID-19 pandemic continues to disrupt life as we know it, it is becoming clearer than ever that a…
COVID-19 pandemic: Health system surge capacity
COVID-19, a novel coronavirus, which emerged in China in December 2019 and has since spread around the world, will test…
China’s young biosimilars sector
China's young biosimilars sector saw a major milestone in December which underlines the sector's rapid growth and significant promise: the…
How to democratize access and prevent the next supermodel medicine
"Supermodel" is not a term I was expecting to hear at this year's ISPOR Europe conference in Copenhagen, which had…